Join Zoë Mullan and other Lancet Group editors to learn more about the SAGER guidelines for sex- and gender-based analyses, explore real research examples, and gain practical tips for responding to the guidelines. 📅 21 October, 2pm BST 👉 Register: hubs.li/Q03FQ_6l0

Our October issue is live! Including research on #vaccination in #rheumatoidarthritis and #hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social

NEW—Unscientific vaccine policy endangers vulnerable patients Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky

Our inaugural issue is out now! 🎉 Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0 Thank you to our authors and reviewers! #medsky #physician-researcher #obgynsky #womenshealthsky

NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky

NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease bit.ly/46xopoY #Medsky #Rheumsky

NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial bit.ly/4nrPIqK #JIA #Medsky #Rheumsky

NEW—Two Reviews on VEXAS syndrome, a disorder caused by an acquired monogenic somatic UBA1 gene mutation which affects ubiquitination and triggers immune dysregulation, leading to diverse clinical and pathological features resembling inflammatory rheumatic diseases #Medsky #Rheumsky #Heamsky

NEW RESEARCH—Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids vs methotrexate and corticosteroids in early, untreated #psoriaticarthritis bit.ly/465KoSC @drailyntan.bsky.social @universityofleeds.bsky.social @nihrleedsbrc.bsky.social #Rheumsky #Medsky

NEW Correspondence—Further progression in patients with systemic sclerosis-associated interstitial lung disease Letter ➡️https://bit.ly/45KZm1v Authors' reply ➡️https://bit.ly/3JKrfhy Linked to this Article ➡️https://bit.ly/4gbwFi0 #Medsky #Rheumsky

📢Calling all aspiring rheumatologists in Sub-Saharan Africa! #EULAR and #AFLAR are enhancing #rheumatology training in Sub-Saharan Africa with free access to high quality online courses. Register here: https://pulse.ly/7n75afapml 📅Deadline: 15 September 2025. #MedicalEducation

NEW Correspondence—Aspirin desensitisation in pregnant individuals with autoimmune disease bit.ly/3Vq74rN #Medsky #Rheumsky

NEW Correspondence—From whole-brain metrics to circuit-specific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis Letter ➡️ bit.ly/4lWADw7 Authors' reply➡️ bit.ly/428azXB Linked to this Article ➡️ bit.ly/4lSNkIf #Medsky #Rheumsky

In our Sept editorial we discuss the complexities of ILD in rheumatic diseases bit.ly/4mR9wmR #Medsky #Rheumsky

Our September issue is live! Including research on #lowbackpain, dual JAK and ROCK inhibition in #rheumatoidarthritis, tapering of TNF inhibitors in #psoriaticarthritis & axial #spondyloarthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW Correspondence—Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus Letter ➡️ bit.ly/3JABcOr Authors' reply ➡️ bit.ly/45kBsd5 Linked to this Article ➡️ bit.ly/3HD17o9

NEW RESEARCH—Personalised gait retraining for medial compartment knee #osteoarthritis: a randomised controlled trial bit.ly/4luS5aO @utah.edu #ASB2025 #Medsky #Rheumsky #BiomechSky

NEW Essay—Expanding the rheumatology lens: should we embrace POTS and post-infectious syndromes? bit.ly/3J82c7R #Medsky #Rheumsky

NEW Correspondence—Preload deficiency as a treatable cause of fatigue and exercise intolerance in #SLE bit.ly/3URufuM #Medsky #Rheumsky

NEW RESEARCH—Cognitive functional therapy, with or without movement sensor biofeedback, produced sustained effects at 3 years versus usual care for people with chronic disabling low back pain bit.ly/3Jm6nwP #Medsky #Rheumsky

NEW RESEARCH—Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip #osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial bit.ly/4mm0iia #Medsky #Rheumsky #Physiosky

Aiming for 7,000 daily steps can reduce risk of chronic diseases, cognitive decline, and death, finds new study. Explore the research in @thelancetph.bsky.social: tinyurl.com/mrvd9uyt

NEW RESEARCH—Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial bit.ly/3GJHgDv #Medsky #Rheumsky

NEW in our August issue—We highlight some of the exciting research developments presented at #EULAR2025 bit.ly/4kYeWeu

Our August issue is live! Including research on patient-reported outcomes in #PMR, maternal autoantibodes and fetal congenital heart block, occupational therapist-led care for hand #OA, and CNS activation in #RA, plus much more! www.thelancet.com/journals/lan... Cover by Sara Gironi Carnevale

NEW Patient voice—Dismissed! My long diagnostic odyssey to Ehlers–Danlos syndrome bit.ly/40tctkR #Medsky #Rheumsky

NEW RESEARCH—Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study bit.ly/4lgcfWx #Medsky #Rheumsky @koraytascilar.bsky.social

Translating AI innovation into clinical practice Read our July editorial www.thelancet.com/journals/lan...

We are a world-leading rheumatology journal While a partial measurement of our impact, we are pleased to share our Impact Factor of 16·4 and CiteScore of 24·3. hubs.li/Q03vf6pR0 #Medsky #Rheumsky

#Biologics is commonly used in #rheumatology but inequitable access exists in the #AsiaPacifc & #LMICs. Our joint podcast with @thelancetrheum.bsky.social with Prof Xue Li discusses the factors that delay access in Asia, any #policy changes & role of #biosimilars. 🔊Listen now: tinyurl.com/ys5x7uxn

NEWS—Debate over interventional procedures for chronic spine pain A clinical guideline published in @bmj.com has sparked controversy for recommending against the use of common interventional procedures for chronic spine pain Find out more 👉https://bit.ly/3Tmnwsb #Medsky #Rheumsky

📣CALL FOR PAPERS ON PPI 📣 1 month to go—deadline is July 31, 2025. We are looking for research on the effectiveness of PPI, mixed methods and qualitative studies examining patient perspectives, as well as studies that have been shaped by lived experience! More info 👇

🧬 Explore our July 2025 issue now! We cover a wide variety of important subjects including influenza, sepsis, lifecourse trajectories, ARDS and much more! 🔗 bit.ly/3P2PVls

NEW RESEARCH—Comparison of findings on contrast-enhanced MRI of the hand, wrist, and forefoot in healthy controls, two at-risk groups, and patients with rheumatoid arthritis: a cohort study bit.ly/44fnyXN

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to Siniša Savić about treatment outcomes in #VEXAS syndrome 👉Apple: bit.ly/3THLJJq 👉Spotify: bit.ly/4naUdX7 Full Article: www.thelancet.com/journals/lan...

NEW RESEARCH—Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from the phase 3 SAPHYR trial bit.ly/4k0mlJQ Plus linked Comment by @drdavidliew.bsky.social & @drceowen.bsky.social bit.ly/4eiha6W #Medsky #Rheumsky

NEW in @lancetchildadol.bsky.social—Treatment of polyarticular juvenile idiopathic arthritis in Latin America: recommendations from the Pan-American League of Associations for Rheumatology bit.ly/460J6d8 @panlar.bsky.social @lancetrh-americ.bsky.social #Medsky #Rheumsky

NEW RESEARCH—Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study bit.ly/45v4wPt #Medsky #Rheumsky

Our July issue is live! Including research on patient-reported outcomes in #SLE, #SystemicSclerosis associated #ILD, autoimmune diseases during #pregnancy, and treatment outcomes in #VEXAS syndrome, plus much more! www.thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW RESEARCH—Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial bit.ly/4e7yoUf #Medsky #Rheumsky

NEW RESEARCH—Exposure to #hydroxychloroquine in early #pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic #lupus erythematosus in Sweden: a nationwide population-based cohort study bit.ly/3FBPz3J @rheumepi.bsky.social Plus, linked Comment bit.ly/3Tknh0D

Hot off the press for #EULAR2025 🔥 Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial bit.ly/4kXPMNn #Medsky #Rheumsky

Attending #EULAR2025 this week? Anna Clark, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q01XgJyP0 #Medsky #Rheumsky

NEW podcast episode🎧 In the third episode of our mini series on cell-based therapies we spoke with Fabian Müller and Melanie Hagen about a newly discovered toxicity of CD19 targeting CAR T-cell therapy Listen🍎https://bit.ly/4jIdLiL or spotify bit.ly/4mUsf1O

NEW REVIEW—Towards precision medicine in antiphospholipid syndrome bit.ly/4kraUf9 #Medsky #Rheumsky #Haemsky

NEW RESEARCH—Trends in the prevalence of autoimmune diseases during #pregnancy in the UK, 2000–21: a retrospective cohort study bit.ly/449fPe3 #Medsky #Rheumsky Plus linked Comment by @hilarykbrown.bsky.social & @nataliescime.bsky.social bit.ly/3HrIPps

NEW RESEARCH—Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis bit.ly/43mmyCb Plus, linked Comment bit.ly/4dFiRej #Medsky #Rheumsky #Physiosky

NEW RESEARCH—A retrospective cohort study from the UK reports treatment outcomes of targeted therapies in patients with #VEXAS syndrome thelancet.com/journals/lan... Plus linked Comment www.thelancet.com/journals/lan... #Medsky #Rheumsky

Attending #EULAR2025? Anna Clark, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q01XgJyP0